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Background. Nonoperative management is the choice of ther-
apy in most patients with primary vesicoureteric reflux (VUR).
Such patients are regularly monitored for breakthrough urinary
tract infection, deterioration of renal function, and progression/
appearance of new scars as the indicators for switching over to
surgical intervention. In this descriptive study, we report our ad-
ditional observations on serial measurement of plasma renin ac-
tivity (PRA) in a group of such children followed prospectively.
Methods. Twenty-six children (16 males and 10 females) with
various grades (grades I to V) of primary VUR were enrolled.
Besides the conventional investigations, we also monitored
PRA. Ureteric reimplantation was performed based on estab-
lished international criteria. PRA levels were correlated with
the need for surgical intervention retrospectively.
Results. Mean age at presentation was 39.3 months (range,
12 to 120 months). Nineteen children (73%) were subjected
to ureteric reimplantation. The mean PRA in this group (N 
19) was 6.97 ng/mL/hour versus 3.28 ng/mL/hour in patients who
were continued on nonoperative management (N  7). Post-
operatively, the PRA reduced and stabilized in all 18 patients
at a mean value of 5.4 ng/mL/hour.
Conclusion. The currently accepted end points of medical
management are inconsistent. On the other hand, 94.7% of
children in the surgical group had shown an activation and a
progressive increase in PRA. Postoperatively, the PRA was
reduced and stabilized in all these patients. Our preliminary
observations suggest that high PRA is a more sensitive indica-
tor for surgical intervention as compared to the existing criteria.
Role of plasma renin activity (PRA) in monitoring the
nonoperative management of primary vesicoureteric re-
flux (VUR) has not been studied in the past. Although
nonoperative management is the choice of therapy in
most patients, surgery is undertaken if children develop
Key words: vesicoureteric reflux, renin, renal scars, ureteric reimplan-
tation, congenital uropathy; reflux nephropathy.
Received for publication April 5, 2003
and in revised form June 4, 2003
Accepted for publication July 1, 2003
 2003 by the International Society of Nephrology
1643
an increase in the grade of reflux and scar, decline in split
renal function (SRF), rise in serum creatinine, decline in
glomerular filtration rate (GFR), and recurrent break-
through urinary tract infection. In this descriptive study,
we report our observations in a group of such children
followed prospectively by serial measurement of PRA.
METHODS
Twenty-six children (16 males and 10 females) with
various grades (grades I to V) of primary VUR were en-
rolled for the study in the Pediatric Urology Clinic of
the All India Institute of Medical Sciences, New Delhi,
India. We monitored PRA, renal scars, SRF, GFR, se-
rum creatinine, blood pressure and episodes of break-
through urinary tract infections at regular intervals. PRA
was measured by radioimmunoassay using commercially
available kit SB REN-2 (Diagnostic Products, Los
Angeles, CA, USA.
Normal PRA from the laboratory were 1 to 12 months
4 to 8 ng/mL/hour; 1 to 3 years  1 to 9 ng/mL/hour; 3
to 6 years  1 to 5 ng/mL/hour; 6 to 15 years  1.4 to
2.6 ng/mL/hour; 15 to 18 years  less than 4.3 ng/mL/
hour. Renal scars were studied using technetium-99m
2,3-dimercaptosuccinic acid (DMSA) scans and were
graded (1 to 4) according to the grading system of Smellie
et al [1]. Grade of reflux was recorded by micturating
cystourethrogram (MCU) using the international criteria
(grades I to V) and SRF was measured by L,L ethylnyl
cysteine (LLEC) radionuclide study. GFR was measured
by multiple blood sampling technique following diethyl-
enetetraaminepentaacetic acid (DTPA) injection. Per-
centage change in GFR was calculated by the formula
adopted by Smellie et al [2](final GFR – initial GFR/
initial GFR 100). Children developing increase in scar
grades, decline in SRF, rise in serum creatinine, decline
in GFR, and recurrent breakthrough urinary tract infec-
tions were identified. Ureteric reimplantation was per-
formed based on established international criteria. PRA
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Table 1. Outcome of patients with grade II reflux in the present series
VUR grade R/L
SRF% R/L Scars R/L Creatinine GFR PRA Creatinine Blood
Serial Age/ Follow-up Follow-up pressure
number gender months I F I F I/preop I/F I/F Surgery months F I/F
1 II/I 60 M 24 52/48 51/49 1/0 1/0 0.6/0.8 68.7/89.0 3.8/3.2 N 3.6 0.8 108/76;
100/80
2 II/I 36 F 36 Rt. NFK Rt. NFK 4/0 4/0 0.7/0.9 68.0/55.5 3.8/6.8 Rt. Nx 5.6 1.0 110/80;
108/80
3 I/II 72 M 24 54/46 52/48 0/1 0/1 0.6/0.7 106.7/108.0 2.6/2.9 N 3.0 0.7 104/72;
100/70
4 II/II 48 F 36 49/51 52/48 0/0 0/0 0.7/0.8 90.1/108.0 3.5/2.6 N 2.8 0.8 100/68;
98/64
Abbreviations are: VUR, vesicoureteric reflux; M, male; F, female; I, initial value; preop, value just before surgery; F, final value; NFK, nonfunctioning kidney;
Nx, nephrectomy; SRF, split renal function; R, right side; L, left side; GFR, glomerular filtration rate; PRA, plasma renin activity expressed in ng/mL; Y, surgery
done; N, no surgery done.
Table 2. Outcome of patients with grade III reflux in the present series
VUR Grade R/L
SRF% R/L Scars R/L Creatinine GFR PRA Creatinine Blood
Serial Age/ Follow-up Follow-up pressure
number gender months I F I F I/preop I/F I/F Surgery months F I/F
1 0/III 36 M 28 80/20 82/18 0/4 0/4 0.8/0.9 52/48 3.8/7.9 Y 5.9 0.8 120/80;
118/80
2 III/III 48 F 36 62/38 66/34 1/3 1/3 0.8/0.8 70/62 3.0/6.2 Y 6.0 0.8 116/78;
114/82
3 III/0 24 M 30 32/64 28/72 2/0 3/0 0.7/0.7 78/80 3.2/3.8 N 3.2 0.7 114/82;
116/80
4 II/III 32 M 24 42/58 48/52 2/1 2/1 0.6/0.7 89/94 3.8/3.5 N 3.9 0.7 106/76;
108/80
5 III/0 120 M 28 42/58 40/60 1/0 1/0 0.7/0.8 98/106 3.2/3.8 N 3.6 0.8 108/74;
106/76
6 III/III 48 F 26 49/51 48/52 2/2 2/2 0.8/0.9 92/90 3.9/5.8 Y 4.6 0.9 120/90;
108/70
7 III/III 60 M 24 48/52 49/51 2/1 2/1 0.8/0.8 100/98 2.6/3.2 N 2.9 0.8 108/72;
110/70
Abbreviations are: M, male; F, female; I, initial value; preop, value just before surgery; F, final value; NFK, nonfunctioning kidney; Nx, nephrectomy; SRF, split
renal function; R, right side; L, left side; GFR, glomerular filtration rate; PRA, plasma renin activity expressed in ng/mL; Y, surgery done; N, no surgery done.
was correlated with the need for surgical intervention
retrospectively.
In this descriptive study, we have used proportion to
summarize qualitative variable. As the number of patients
are small, no statistical inference in the form of P value
is computed. In this pilot study, in addition to propor-
tions, we have also provided the raw data for the benefit
of readers for an understanding at the patient level.
RESULTS
Twenty-six children (16 males and 10 females) were
enrolled in the study. Mean age at presentation was 39.3
months (range, 13 to 120 months). Nineteen children
(73%) were subjected to surgical intervention. As a pol-
icy, these patients underwent bilateral Cohen’s ureteric
reimplantation, even when the reflux was unilateral. The
distribution of patients with various grades of reflux is
indicated in Tables 1 to 4. Nine out of 26 patients showed
a progression in scar grade (Table 5), two out of 26
showed a fall in SRF of more or equal to 5%, 11 out of
26 children had serum creatinine levels higher than the
upper limit for the age, eight out of 26 children were
detected to have hypertension, and two out of 26 had
breakthrough urinary tract infections (more than two
episodes/6 months) warranting surgery. Significant fall
in GFR (10 mL/min/1.7 m2) was seen only in two out
of 26 patients. All children in the surgical group, except
one (18 out of 19) (94.7%), had shown an activation and
a progressive increase in PRA. The mean PRA in this
group (N  19) was 6.97 ng/mL/hour versus 3.28 ng/mL/
hour in patients who were continued on nonoperative
management (N  7). Postoperatively, the PRA was
reduced and stabilized in all 18 patients at a mean value
of 5.4 ng/mL/hour, which was higher than normal. Five
out of eight patients had normalization of their blood
pressure. Only one patient in the surgical group with
PRA within the normal range had presented with bilat-
eral grade V reflux with nephropathy (four of four scars)
and chronic renal failure (CRF) (creatinine 5.6 mg/dL,
GFR 20 mL/min/1.73 m2). This child had breakthrough
urinary tract infections (three episodes in a 6-month
period), a falling GFR, and was subjected to bilateral
ureteric reimplantation. Postoperatively, he is free of
urinary tract infections, but continues in CRF, hyperten-
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Table 3. Outcome of patients with grade IV reflux in the present series
VUR Grade R/L
SRF% R/L Scars R/L Creatinine GFR PRA Creatinine Blood
Serial Age/ Follow-up Follow-up pressure
number gender months I F I F I/preop I/F I/F Surgery months F I/F
1 III/IV 13 M 32 52/48 56/44 1/3 1/4 0.8/0.9 60/58 4.8/6.3 Y 6.2 0.8 128/90;
120/86
2 I/IV 16 F 36 68/32 72/28 0/3 0/4 0.9/1.1 58/56 6.2/7.3 Y 6.5 1.1 110/80;
120/80
3 IV/IV 20 M 28 51/49 54/46 1/2 1/3 0.8/0.9 98/92 2.2/6.8 Y 5.0 0.8 110/74;
108/70
4 III/IV 18 M 30 62/38 60/40 1/2 1/2 0.9/0.9 70/62 3.0/6.2 Y 5.6 0.9 108/72;
110/70
5 III/IV 28 F 36 58/42 60/40 2/3 2/3 0.7/0.9 60/58 2.6/5.7 Y 3.2 0.8 128/89;
118/80
6 I/IV 30 F 36 65/35 70/30 0/3 0/3 0.6/0.8 98/89 3.8/6.8 Y 6.2 0.8 118/76;
120/80
7 II/IV 12 M 28 70/30 72/28 1/4 1/4 0.8/1.1 78/76 3.2/7.42 Y 3.6 0.9 108/72;
118/70
8 III/IV 16 F 28 58/42 56/44 2/3 2/3 0.7/0.9 75/68 3.0/5.9 Y 4.6 0.8 118/82;
118/80
Abbreviations are: M, male; F, female; I, initial value; preop, value just before surgery; F, final value; NFK, nonfunctioning kidney; Nx, nephrectomy; SRF, split
renal function; R, right side; L, left side; GFR, glomerular filtration rate; PRA, plasma renin activity expressed in ng/mL; Y, surgery done; N, no surgery done.
Table 4. Outcome of patients with grade V reflux in the present series
VUR Grade R/L
SRF% R/L Scars Creatinine GFR PRA Creatinine Blood
Serial Age/ Follow-up Follow-up pressure
number gender months I F I F I/preop I/F I/F Surgery months F I/F
1 III/V 36 M 24 68/32 72/28 1/4 1/4 0.9/1.1 58/49 3.6/5.7 Y 5.6 1.0 118/76;
120/80
2 V/V 48 F 18 34/66 30/70 4/4 4/4 3.0/2.8 17.4/15.4 5.8/13.3 Y 10.8 2.2 132/90;
130/80
3 V/V 60 F 12 40/60 42/58 3/4 4/4 1.8/1.7 38/28 4.0/6.2 Y 5.0 1.5 126/90;
118/76
4 V/V 36 F 12 82/18 90/10 1/4 2/4 1.2/1.3 66/35 6.14/13.9 Y 10.0 1.4 128/89;
120/88
5 III/V 28 M 18 60/40 62/38 1/3 1/3 0.9/1.1 68/65 2.45/7.68 Y 3.6 1.0 118/74;
112/76
6 V/V 32 M 17 90/10 88/12 3/4 4/4 4.5/5.6 25/20 2.4/2.6 Y 2.1 5.8 140/100;
142/100
7 IV/V 46 F 12 Lt. Poor fn. 4/4 4/4 3.0/3.8 35/18 3.6/4.1 Y 2.8 2.6 138/92;
140/90
Abbreviations are: M, male; F, female; I, initial value; preop, value just before surgery; F, final value; NFK, nonfunctioning kidney; Nx, nephrectomy; SRF, split
renal function; R, right side; L, left side; GFR, glomerular filtration rate; PRA, plasma renin activity expressed in ng/ml; Y, surgery done; N, no surgery done.
Table 5. The association of various indications for surgery vı´s-a-vı´s plasma renin activity (PRA) in patients who required ureteric
reimplantation (out of 26 patients initially managed nonoperatively, 19 required surgery) (73%)
Progression Rise in PRA High aEpisodes
Indications of scars Fall in SRF creatinine 4.0 ng/mL blood pressure of UTI Fall in GFR
for surgery N  9 N  2 N  11 N  18 N  8 N  2 N  6
Percentage association 47.3 10.5 57.9 94.7 42.1 10.5 31.5
Abbreviations are: SRF, split renal function; PRA, plasma renin activity; UTI, urinary tract infection (a more than two episodes of breakthrough UTIs in 6 months
were considered significant); GFR, glomerular filtration rate.
sion, and a low PRA. None of the other patients in the
surgical group had any significant deterioration of renal
function during the mean follow-up of 26.2 months
(range, 12 to 36 months).
DISCUSSION
Traditionally, children with primary VUR and stable
renal function are managed nonoperatively with the ex-
pectation of spontaneous resolution with age. Although
the present criteria for surgical intervention are widely
accepted, yet, the long-term safety of continued non-
operative management has constantly been under scru-
tiny [3].
The currently accepted end points of medical manage-
ment are inconsistent as indicated by an analysis of the
present series. Patients who underwent surgery had vari-
able criteria (Tables 1 to 4) and none of them met all
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the criteria for surgical intervention (Table 5). These
criteria are also irreversible. On the other hand, all chil-
dren in the surgical group except one (18 out of 19)
(94.7%) had shown an activation and a progressive in-
crease in PRA. The mean PRA in this group (N  19)
was 6.97 ng/mL/hour versus 3.28 ng/mL/hour in patients
who were continued on nonoperative management (N
7). Postoperatively, the PRA reduced and stabilized in
all 18 patients at a mean value of 5.4 ng/mL/hour, which
is higher than normal.
Since the presently accepted criteria for intervention
are not present uniformly in all the patients requiring
surgery, the safety of continued nonoperative manage-
ment is questionable. This issue especially assumes sig-
nificance since the existing criteria for surgery are irre-
versible. Although, in some other congenital uropathies,
a nonoperative approach is currently the mainstay of
treatment [4, 5], there is continued search for early mark-
ers for surgical intervention. Study of the activated renin-
angiotensin system (RAS) is one such attempt [6, 7].
Children with persistent reflux but preserved renal
parameters are managed conservatively with the expec-
tation of spontaneous resolution with age. However, chil-
dren with persistent reflux of moderate to higher grade
(III, IV, or V) who apparently have stable GFR, SRF,
and serum creatinine pose difficulty in management.
Many authors advocate that surgical correction does not
alter the outcome in children with severe bilateral VUR
and bilateral nephropathy [2, 8]. Many such children end
up with early hypertension, CRF, and even end-stage
renal disease (ESRD). Arterial damage in the area of
renal scarring presumably leads to segmental ischemia
and renin-driven hypertension. Recently, several studies
have shown that renal scarring with or without VUR
leads to activation of RAS, atrial natriuretic peptide,
aldosterone, catecholamines, and Na-K ATPase, which, in
turn, are responsible for pediatric hypertension, elevated
resting heart rate, and palpitation [9, 10]. Chronic activa-
tion of renin-angiotensin-aldosterone system (RAAS) is
associated with adverse structural remodeling of right
and left ventricles characterized by reparative (i.e., mi-
croscopic scars) and reactive (i.e., perivascular/intersti-
tial) fibrosis, leading to increased cardiovascular mortal-
ity [11]. Some authors have speculated that the unique
scar associated redistribution of renin may play a patho-
physiologic role in the progression of renal disease, in-
cluding progression of scars (formation of atubular glo-
meruli due to periglomerular sclerosis) [12, 13]. Elevated
renin may be related to eventual hypertension for some
patients, but others with high renin remain normoten-
sive, while a small number revert to normal with extended
follow-up [14]. In a 5-year prospective study, patients
with long-standing reflux nephropathy were found to
have a higher mean PRA [14] and even hyper-reninemic-
normotensive patients carry a 10% to 20% risk of devel-
oping hypertension. Identification of early activation of
RAS is, therefore, important since PRA may prove to
be of value in early identification of children at risk of
developing hypertension [15].
Both sterile and infected urine is known to produce
parenchymal damage in different situations [3]. Preven-
tion of reflux-associated renal changes may offer some
benefit in reducing the incidence of hypertension, pro-
gression of scars, and cardiovascular changes [16]. In our
study, 69.2% of patients (18 out of 26) showed activation
of RAS and escalating levels of PRA.
In the present series, more than 96% had reflux ne-
phropathy, eight out of 26 (30.7%) patients were hyper-
tensive (seven had raised PRA and one had CRF and
normal PRA) and 11 out of 26 (42.3%) were hyper-
reninemic normotensive. All of them (N  19) were
subjected to surgery. Postoperative follow-up showed
reduction and stabilization of PRA in all the operated
patients (19 out of 19), albeit at a mean PRA of 5.41 ng/
mL/hour, which was higher than normal. Five out of
eight patients (62.5%) showed normalization of blood
pressure. At a mean of 26.2 months follow-up, only 7.6%
patients (two out of 26) continue to be hypertensive
requiring minimal dose of anti-hypertensive medica-
tions. None of the patients complain of palpitation or
any other cardiovascular symptom. Hyperreninemic nor-
motensive patients (N  11) are under follow-up and
constitute a risk group for hypertension, proteinuria, and
other systemic adverse effects of hyperreninemia.
Hypertension is related to the grade of reflux and the
severity of scarring in most series, especially with bilat-
eral involvement [17–19]. Higher scar grades (2.9/3.6 vs.
1.09/3.0), more bilateral nephropathy (100% vs. 63.6%),
and higher mean PRA (7.9 ng/mL/hour vs 6.8 ng/mL/hour)
were seen among the hypertensive group versus the nor-
motensive group.
As this is a descriptive study, we recommend further
prospective studies to establish the role of PRA as a more
sensitive marker in monitoring the management of pa-
tients with primary VUR. The existing criteria, once
attained, are irreversible. Subclinical urinary tract infec-
tions and high pressure sterile intrarenal reflux are pro-
posed to be some of the factors that lead to progressive
nephropathy in patients under adequate medical therapy
[3, 20]. It is, therefore, imperative to establish a more
sensitive marker, such as PRA, in order to decide the
most appropriate time for surgical intervention in nonop-
eratively treated patients with VUR and to prevent the
deleterious effects of RAAS activation.
Our results suggest that serial measurement of PRA
may help in better stratification of patients with moder-
ate to high grade (III, IV, and V) VUR and reflux ne-
phropathy with respect to management and prognosis.
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